Eyenovia specializes in the commercialization and development of Optejet, a device used for presbyopia and pediatric progressive myopia.
The Redwood facility, which was announced operational in 2022, focuses on Optejet pharmaceutical manufacturing finishing operations, including drug loading, labeling and packaging prior to distribution, according to a June 6 press release.
The new 10,000-square-foot Reno facility will focus on device manufacturing.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
